In the work described here, our results reveal that Ad5GS3 exerted much higher oncolytic activity against stage IV lung adenocarcinoma than stages IA and IB lung adenocarcinoma, which was associated with higher levels of nuclear YB-1 and cytoplasmic MDR1 expression in the late stage tumor. The gene discussed is YBX1; the disease is neoplasm.